PSUR for moxifloxacin identificeret store sikkerhedsproblemer, herunder livstruende tilfælde af hepatotoksicitet.
In October 2007, the assessment of the 15th and 16th PSUR for moxifloxacin identified major safety concerns including life threatening hepatotoxicity cases.